ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「プロバイオティクスとうつ症状の関連を12件の臨床試験で検証」の検索結果

1,458 件中 10 件を表示 (3142 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(probiotics[MeSH] OR probiotic*) AND (depression[MeSH] OR depressive symptoms OR depressive disorder)

💡 プロバイオティクスとうつ症状の関連について、MeSH用語と類義語を組み合わせた標準的な検索クエリ

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Gut microbiota and its metabolites in depression: from pathogenesis to treatment.

    Lanxiang Liu, Haiyang Wang, Xueyi Chen 他 · EBioMedicine · 2023

    Major depressive disorder is one of the most disabling mental disorders worldwide. Increasing preclinical and clinical studies have highlighted that compositional and functional (e.g., metabolite) changes in gut microbiota, known as dysbiosis, are associated with the onset and progression of depression via regulating the gut-brain axis. However, the gut microbiota and their metabolites present a d…

    📄 PubMed で読む (PMID: 36963238)
  • The Microbiota-Gut-Brain Axis in Psychiatric Disorders.

    Aleksandra Góralczyk-Bińkowska, Dagmara Szmajda-Krygier, Elżbieta Kozłowska 他 · International journal of molecular sciences · 2022

    Modulating the gut microbiome and its influence on human health is the subject of intense research. The gut microbiota could be associated not only with gastroenterological diseases but also with psychiatric disorders. The importance of factors such as stress, mode of delivery, the role of probiotics, circadian clock system, diet, and occupational and environmental exposure in the relationship bet…

    📄 PubMed で読む (PMID: 36232548)
  • Effects of Prebiotics and Probiotics on Symptoms of Depression and Anxiety in Clinically Diagnosed Samples: Systematic Review and Meta-analysis of Randomized Controlled Trials.

    Afrida Asad, Megan Kirk, Sufen Zhu 他 · Nutrition reviews · 2025

    The use of prebiotics and probiotics as a treatment for psychiatric conditions has gained interest due to their potential to modulate the gut-brain axis. This review aims to assess the effectiveness of these interventions in reducing symptoms of depression and anxiety in psychiatric populations. The aim was to comprehensively review and appraise the effectiveness of prebiotic, probiotic, and synbi…

    📄 PubMed で読む (PMID: 39731509)
  • Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.

    Maria Ines Pinto-Sanchez, Geoffrey B Hall, Kathy Ghajar 他 · Gastroenterology · 2017

    Probiotics can reduce symptoms of irritable bowel syndrome (IBS), but little is known about their effects on psychiatric comorbidities. We performed a prospective study to evaluate the effects of Bifidobacterium longum NCC3001 (BL) on anxiety and depression in patients with IBS. We performed a randomized, double-blind, placebo-controlled study of 44 adults with IBS and diarrhea or a mixed-stool pa…

    📄 PubMed で読む (PMID: 28483500)
  • The Microbiome-Gut-Brain Axis in Health and Disease.

    Timothy G Dinan, John F Cryan · Gastroenterology clinics of North America · 2017

    Gut microbes are capable of producing most neurotransmitters found in the human brain. Evidence is accumulating to support the view that gut microbes influence central neurochemistry and behavior. Irritable bowel syndrome is regarded as the prototypic disorder of the brain-gut-microbiota axis that can be responsive to probiotic therapy. Translational studies indicate that certain bacteria may have…

    📄 PubMed で読む (PMID: 28164854)
  • Psychobiotics: a novel class of psychotropic.

    Timothy G Dinan, Catherine Stanton, John F Cryan 他 · Biological psychiatry · 2013

    Here, we define a psychobiotic as a live organism that, when ingested in adequate amounts, produces a health benefit in patients suffering from psychiatric illness. As a class of probiotic, these bacteria are capable of producing and delivering neuroactive substances such as gamma-aminobutyric acid and serotonin, which act on the brain-gut axis. Preclinical evaluation in rodents suggests that cert…

    📄 PubMed で読む (PMID: 23759244)
  • Prebiotic and Probiotic Modulation of the Microbiota-Gut-Brain Axis in Depression.

    Daniel E Radford-Smith, Daniel C Anthony · Nutrients · 2023

    Emerging evidence demonstrates that alterations to the gut microbiota can affect mood, suggesting that the microbiota-gut-brain (MGB) axis contributes to the pathogenesis of depression. Many of these pathways overlap with the way in which the gut microbiota are thought to contribute to metabolic disease progression and obesity. In rodents, prebiotics and probiotics have been shown to modulate the …

    📄 PubMed で読む (PMID: 37111100)
  • Inflammatory Depression-Mechanisms and Non-Pharmacological Interventions.

    Klara Suneson, Jesper Lindahl, Simon Chamli Hårsmar 他 · International journal of molecular sciences · 2021

    Treatment of depression is hampered by the failure to identify distinct symptom profiles with distinct pathophysiologies that differentially respond to distinct treatments. We posit that inflammatory depression is a meaningful depression subtype associated with specific symptoms and biological abnormalities. We review several upstream, potentially causative, mechanisms driving low-grade inflammati…

    📄 PubMed で読む (PMID: 33561973)
  • Mind, Mood and Microbiota-Gut-Brain Axis in Psychiatric Disorders.

    Corneliu Toader, Nicolaie Dobrin, Daniel Costea 他 · International journal of molecular sciences · 2024

    Psychiatric disorders represent a primary source of disability worldwide, manifesting as disturbances in individuals' cognitive processes, emotional regulation, and behavioral patterns. In the quest to discover novel therapies and expand the boundaries of neuropharmacology, studies from the field have highlighted the gut microbiota's role in modulating these disorders. These alterations may influe…

    📄 PubMed で読む (PMID: 38542314)
  • Multi-Probiotics ameliorate Major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation.

    Peijun Tian, Renying Zou, Luyao Wang 他 · Journal of advanced research · 2023

    Major depressive disorder (MDD) is a leading global psychiatric disease. MDD is highly comorbid with gastrointestinal abnormalities, such as gut motility dysfunction. An effective strategy to manage depression and its accompanying gastrointestinal symptoms is warranted. Three probiotic strains (Bifidobacterium breve CCFM1025, Bifidobacterium longum CCFM687, and Pediococcus acidilactici CCFM6432) h…

    📄 PubMed で読む (PMID: 35618633)